What is Zacks Research's Forecast for CME Group Q3 Earnings?

Key Points

• Zacks Research has lowered the Q3 2025 earnings estimate for CME Group to $2.72 per share, down from a previous estimate of $2.74, with the full-year consensus estimate at $10.49 per share.
• CME Group recently reported earnings of $2.96 per share for the last quarter, exceeding analysts' expectations, with a year-over-year revenue increase of 10.4% to $1.69 billion.
• The company declared a quarterly dividend of $1.25, amounting to an annualized dividend yield of 1.8%, with a payout ratio of 48.40%.

CME Group Inc. (NASDAQ:CME - Free Report) - Research analysts at Zacks Research reduced their Q3 2025 earnings estimates for shares of CME Group in a research note issued to investors on Tuesday, August 12th. Zacks Research analyst T. De now expects that the financial services provider will post earnings per share of $2.72 for the quarter, down from their prior forecast of $2.74. The consensus estimate for CME Group's current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group's Q4 2025 earnings at $2.65 EPS, Q1 2026 earnings at $2.86 EPS, Q1 2027 earnings at $3.11 EPS and Q2 2027 earnings at $3.10 EPS.

Other research analysts also recently issued research reports about the stock. Piper Sandler lifted their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Citigroup lifted their price objective on shares of CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a research note on Thursday, July 3rd. Barclays set a $298.00 price objective on shares of CME Group and gave the company an "equal weight" rating in a research note on Thursday, July 24th. JPMorgan Chase & Co. decreased their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Finally, Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $261.93.

CME Group Stock Down 0.3%

Shares of CME Group stock traded down $0.78 on Thursday, reaching $273.92. The stock had a trading volume of 2,055,786 shares, compared to its average volume of 2,086,143. The company has a 50 day moving average price of $275.52 and a 200 day moving average price of $267.37. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 1 year low of $204.16 and a 1 year high of $290.79. The stock has a market capitalization of $98.72 billion, a P/E ratio of 26.52, a P/E/G ratio of 4.86 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the business posted $2.56 EPS. The company's quarterly revenue was up 10.4% compared to the same quarter last year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the transaction, the general counsel owned 6,708 shares of the company's stock, valued at $1,861,470. This trade represents a 5.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Charles P. Carey sold 500 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the completion of the transaction, the director directly owned 4,900 shares of the company's stock, valued at approximately $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 2,450 shares of company stock valued at $676,663 over the last quarter. 0.30% of the stock is owned by insiders.

Institutional Trading of CME Group

Hedge funds have recently added to or reduced their stakes in the company. Webster Bank N. A. grew its position in CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after buying an additional 60 shares during the last quarter. Highline Wealth Partners LLC raised its stake in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock worth $26,000 after buying an additional 43 shares during the last quarter. Wayfinding Financial LLC acquired a new position in shares of CME Group during the 1st quarter worth $25,000. Cornerstone Planning Group LLC raised its stake in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. Finally, Sagard Holdings Management Inc. acquired a new position in CME Group in the 2nd quarter valued at about $30,000. Institutional investors and hedge funds own 87.75% of the company's stock.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.